These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7694821)

  • 1. Characterization of Mycobacterium fortuitum isolates from sternotomy wounds by antimicrobial susceptibilities, plasmid profiles, and ribosomal ribonucleic acid gene restriction patterns.
    Yew WW; Wong PC; Woo HS; Yip CW; Chan CY; Cheng FB
    Diagn Microbiol Infect Dis; 1993; 17(2):111-7. PubMed ID: 7694821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery.
    Wallace RJ; Musser JM; Hull SI; Silcox VA; Steele LC; Forrester GD; Labidi A; Selander RK
    J Infect Dis; 1989 Apr; 159(4):708-16. PubMed ID: 2926161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study.
    Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK
    Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.
    Wallace RJ; Brown BA; Silcox VA; Tsukamura M; Nash DR; Steele LC; Steingrube VA; Smith J; Sumter G; Zhang YS
    J Infect Dis; 1991 Mar; 163(3):598-603. PubMed ID: 1995732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks.
    Hector JS; Pang Y; Mazurek GH; Zhang Y; Brown BA; Wallace RJ
    J Clin Microbiol; 1992 May; 30(5):1250-5. PubMed ID: 1583127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged postprocedural outbreak of Mycobacterium massiliense infections associated with ultrasound transmission gel.
    Cheng A; Sheng WH; Huang YC; Sun HY; Tsai YT; Chen ML; Liu YC; Chuang YC; Huang SC; Chang CI; Chang LY; Huang WC; Hsueh PR; Hung CC; Chen YC; Chang SC
    Clin Microbiol Infect; 2016 Apr; 22(4):382.e1-382.e11. PubMed ID: 26794030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection.
    Yew WW; Kwan SY; Ma WK; Khin MA; Mok CK
    Chest; 1989 Nov; 96(5):1150-2. PubMed ID: 2805845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Outbreak of Mycobacterium chimaera Infection After Open-Chest Heart Surgery.
    Sax H; Bloemberg G; Hasse B; Sommerstein R; Kohler P; Achermann Y; Rössle M; Falk V; Kuster SP; Böttger EC; Weber R
    Clin Infect Dis; 2015 Jul; 61(1):67-75. PubMed ID: 25761866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010-2016.
    Buser GL; Laidler MR; Cassidy PM; Moulton-Meissner H; Beldavs ZG; Cieslak PR
    Emerg Infect Dis; 2019 May; 25(5):849-855. PubMed ID: 31002056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic repetitive DNA sequences in Mycobacterium tuberculosis detected with a gene probe from a Mycobacterium fortuitum plasmid.
    Zainuddin ZF; Dale JW
    J Gen Microbiol; 1989 Sep; 135(9):2347-55. PubMed ID: 2576436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense.
    Wallace RJ; Brown-Elliott BA; Brown J; Steigerwalt AG; Hall L; Woods G; Cloud J; Mann L; Wilson R; Crist C; Jost KC; Byrer DE; Tang J; Cooper J; Stamenova E; Campbell B; Wolfe J; Turenne C
    J Clin Microbiol; 2005 Dec; 43(12):5925-35. PubMed ID: 16333077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtyping by genome and plasmid analysis of Campylobacter jejuni serogroups O1 and O2 (Penner) from sporadic and outbreak cases of human diarrhoea.
    Fayos A; Owen RJ; Hernandez J; Jones C; Lastovica A
    Epidemiol Infect; 1993 Dec; 111(3):415-27. PubMed ID: 7505748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postdischarge surveillance system for nontuberculous mycobacterial infection at a Brazilian regional referral hospital after an outbreak.
    Chiquin CA; Silva JH; Ciruelos MJ; Lemes MC; Penteado-Filho SR; Tuon FF
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):399-401. PubMed ID: 19220163
    [No Abstract]   [Full Text] [Related]  

  • 15. Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation.
    Burns DN; Wallace RJ; Schultz ME; Zhang YS; Zubairi SQ; Pang YJ; Gibert CL; Brown BA; Noel ES; Gordin FM
    Am Rev Respir Dis; 1991 Nov; 144(5):1153-9. PubMed ID: 1952447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ribosomal RNA gene restriction patterns to investigate two outbreaks of Campylobacter enteritis in Melbourne, Australia.
    Tee W; Mayall B; Lucas CR; Rayner R; Pearson S; Dwyer B
    J Med Microbiol; 1992 Dec; 37(6):385-8. PubMed ID: 1281233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a genetically distinct subspecies of Mycobacterium kansasii.
    Ross BC; Jackson K; Yang M; Sievers A; Dwyer B
    J Clin Microbiol; 1992 Nov; 30(11):2930-3. PubMed ID: 1280644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients.
    Chand M; Lamagni T; Kranzer K; Hedge J; Moore G; Parks S; Collins S; Del Ojo Elias C; Ahmed N; Brown T; Smith EG; Hoffman P; Kirwan P; Mason B; Smith-Palmer A; Veal P; Lalor MK; Bennett A; Walker J; Yeap A; Isidro Carrion Martin A; Dolan G; Bhatt S; Skingsley A; Charlett A; Pearce D; Russell K; Kendall S; Klein AA; Robins S; Schelenz S; Newsholme W; Thomas S; Collyns T; Davies E; McMenamin J; Doherty L; Peto TE; Crook D; Zambon M; Phin N
    Clin Infect Dis; 2017 Feb; 64(3):335-342. PubMed ID: 27927870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-restriction-fragment analysis of Mycobacterium kansasii genomic DNA and its application in molecular typing.
    Iinuma Y; Ichiyama S; Hasegawa Y; Shimokata K; Kawahara S; Matsushima T
    J Clin Microbiol; 1997 Mar; 35(3):596-9. PubMed ID: 9041396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.